EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 170 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $9,000 | -55.0% | 316 | -57.6% | 0.00% | – |
| Q3 2022 | $20,000 | -4.8% | 745 | +61.3% | 0.00% | – |
| Q2 2022 | $21,000 | +75.0% | 462 | +92.5% | 0.00% | – |
| Q1 2022 | $12,000 | -98.5% | 240 | -98.3% | 0.00% | -100.0% |
| Q3 2019 | $816,000 | +92.5% | 14,423 | +89.2% | 0.00% | +100.0% |
| Q2 2019 | $424,000 | +0.5% | 7,622 | -8.8% | 0.00% | 0.0% |
| Q1 2019 | $422,000 | +25.2% | 8,360 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $337,000 | +200.9% | 8,360 | +415.4% | 0.00% | +100.0% |
| Q3 2018 | $112,000 | -74.4% | 1,622 | -80.5% | 0.00% | -50.0% |
| Q1 2018 | $438,000 | +0.2% | 8,308 | +1.6% | 0.00% | 0.0% |
| Q4 2017 | $437,000 | -66.4% | 8,180 | -50.4% | 0.00% | -50.0% |
| Q2 2017 | $1,300,000 | – | 16,486 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |